Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3676782018 | Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3676784017 | Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Aspirin compound preparation | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing butalbital (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing caffeine (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing caffeine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Caffeine | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Bronchodilator (substance) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Stimulant (substance) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Aspirin (substance) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Butalbital (substance) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Xanthine | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing aspirin and butalbital and caffeine (medicinal product) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Phosphodiesterase inhibitor | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Xanthine | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing caffeine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing aspirin in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Caffeine | true | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Aspirin (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Butalbital (substance) | false | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Butalbital (substance) | true | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Caffeine | false | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Caffeine | false | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Aspirin (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Aspirin (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 325 | false | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Aspirin (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Caffeine | true | Inferred relationship | Some | 1 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Butalbital (substance) | true | Inferred relationship | Some | 3 | |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Aspirin- and butalbital- and caffeine-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing only aspirin and butalbital and caffeine in oral dose form (medicinal product form) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets